Keyphrases
Treatment Outcome
100%
Asian children
100%
Second-line Treatment
100%
Hair Samples
100%
Lopinavir
100%
Virological Failure
57%
Antiretroviral
57%
Hair Concentrations
57%
HIV RNA
28%
ARV Treatment
28%
Pill Count
28%
Self-reported Adherence
28%
Children with HIV
28%
Odds Ratio
14%
Antiretroviral Therapy
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
CD4 Count
14%
HIV Patients
14%
Plasma Samples
14%
Visual Analog Scale
14%
Drug Levels
14%
CD4%
14%
Protease Inhibitors
14%
Children at Risk
14%
Pearson Correlation Coefficient
14%
Therapy Regimen
14%
Long-term Adherence
14%
Monitoring Study
14%
Prospective Monitoring
14%
Longitudinal Cohort
14%
Adherence Measures
14%
Nursing and Health Professions
Treatment Outcome
100%
Lopinavir
100%
Human Immunodeficiency Virus
50%
Pill
33%
Odds Ratio
16%
Correlation Coefficient
16%
Visual Analog Scale
16%
Antiretroviral Therapy
16%
Proteinase Inhibitor
16%
CD4 Lymphocyte Count
16%
Liquid Chromatography-Mass Spectrometry
16%
Lopinavir Plus Ritonavir
16%
Drug Blood Level
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Plasma
100%
CD4
33%
CD4 Lymphocyte Count
33%
Drug Blood Level
33%
Liquid Chromatography Tandem Mass Spectrometry
33%
Medicine and Dentistry
Lopinavir
100%
Human Immunodeficiency Virus
50%
Antiretroviral Therapy
16%
Visual Analog Scale
16%
Cell Count
16%
Proteinase Inhibitor
16%
Liquid Chromatography-Mass Spectrometry
16%
Lopinavir/Ritonavir
16%
Odds Ratio
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lopinavir
100%
HIV
50%
Proteinase Inhibitor
16%
Lopinavir Plus Ritonavir
16%